Lee Ponsky
Overview
Explore the profile of Lee Ponsky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
1519
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Park S, Lee S, Park S, Kim E, Pizzol D, Trott M, et al.
BJU Int
. 2023 Sep;
133(4):387-399.
PMID: 37667439
Objective: To investigate the prevalence and trends of essential study design elements in preclinical urological studies, as well as key factors that may improve methodological rigour, as the demand for...
12.
Zaorsky N, Proudfoot J, Jia A, Zuhour R, Vince Jr R, Liu Y, et al.
JNCI Cancer Spectr
. 2023 Aug;
7(5).
PMID: 37525535
Background: Management of localized or recurrent prostate cancer since the 1990s has been based on risk stratification using clinicopathological variables, including Gleason score, T stage (based on digital rectal exam),...
13.
Li L, Shiradkar R, Tirumani S, Bittencourt L, Fu P, Mahran A, et al.
Eur J Radiol Open
. 2023 Jul;
10:100496.
PMID: 37396490
Background: around one third of clinically significant prostate cancer (CsPCa) foci are reported to be MRI non-visible (MRI─). Objective: To quantify the differences between MR visible (MRI+) and MRI CsPCa...
14.
Weinstein I, Wu X, Arenas-Gallo C, Zhu A, Brant A, Al Hussein Al Awamlh B, et al.
Urology
. 2023 Jun;
179:106-111.
PMID: 37328009
Objective: To investigate the utilization of holmium laser enucleation of the prostate (HoLEP) using a large real-world cohort. We compare the safety, readmission, and retreatment rates of HoLEP to other...
15.
Wang M, Ng M, Bukavina L, Mahran A, Mishra K, Buzzy C, et al.
Urol Pract
. 2023 Jun;
7(1):1-6.
PMID: 37317398
Introduction: To measure the cost expenditure associated with renal cyst surveillance, we examined renal cyst surveillance patterns at our institution and the associated surplus cost of unindicated imaging. Methods: Patients...
16.
Mishra K, Ng M, Wang M, Mahran A, Callegari M, Sopko E, et al.
Urol Pract
. 2023 Jun;
7(6):467-473.
PMID: 37287171
Introduction: A 2015 survey of members of the American Urological Association found the majority of urologists (62.7%) work with an advanced practice provider. The aim of this study was to...
17.
Mishra K, Ng M, Wang M, Mahran A, Callegari M, Sopko E, et al.
Urol Pract
. 2023 Jun;
7(6):472-473.
PMID: 37287169
No abstract available.
18.
Weinstein I, Wu X, Hill A, Brennan D, Omil-Lima D, Basourakos S, et al.
Eur Urol Oncol
. 2023 May;
6(4):355-365.
PMID: 37236832
Context: The evidence supporting multiparametric magnetic resonance imaging (MRI) targeting for biopsy is nearly exclusively based on biopsy pathologic outcomes. This is problematic, as targeting likely allows preferential identification of...
19.
Luo D, Wang X, Ramamurthy G, Walker E, Zhang L, Shirke A, et al.
Prostate
. 2023 May;
83(12):1176-1185.
PMID: 37211857
Background: Male dogs can develop spontaneous prostate cancer, which is similar physiologically to human disease. Recently, Tweedle and coworkers have developed an orthotopic canine prostate model allowing implanted tumors and...
20.
Bukavina L, Dubin J, Isali I, Calaway A, Mortach S, Loeb S, et al.
Urol Pract
. 2023 May;
9(4):331-339.
PMID: 37145779
Introduction: The dramatic reduction of clinical and research activities within medical and surgical departments during COVID-19, coupled with the inability of medical students to engage in research, away rotations and...